These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19425533)

  • 1. Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection.
    Boeggeman E; Ramakrishnan B; Pasek M; Manzoni M; Puri A; Loomis KH; Waybright TJ; Qasba PK
    Bioconjug Chem; 2009 Jun; 20(6):1228-36. PubMed ID: 19425533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method.
    Boeggeman E; Ramakrishnan B; Kilgore C; Khidekel N; Hsieh-Wilson LC; Simpson JT; Qasba PK
    Bioconjug Chem; 2007; 18(3):806-14. PubMed ID: 17370997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases.
    Qasba PK
    Bioconjug Chem; 2015 Nov; 26(11):2170-5. PubMed ID: 26065635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
    MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
    Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
    Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
    Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
    PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile.
    Strasser R; Castilho A; Stadlmann J; Kunert R; Quendler H; Gattinger P; Jez J; Rademacher T; Altmann F; Mach L; Steinkellner H
    J Biol Chem; 2009 Jul; 284(31):20479-85. PubMed ID: 19478090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line.
    Kim J; Luo H; White W; Rees W; Venkat R; Albarghouthi M
    MAbs; 2020; 12(1):1844928. PubMed ID: 33171078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramolecular N-glycan/polypeptide interactions observed at multiple N-glycan remodeling steps through [(13)C,(15)N]-N-acetylglucosamine labeling of immunoglobulin G1.
    Barb AW
    Biochemistry; 2015 Jan; 54(2):313-22. PubMed ID: 25551295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain.
    Raju TS; Scallon B
    Biotechnol Prog; 2007; 23(4):964-71. PubMed ID: 17571902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
    Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
    Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody.
    Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D
    MAbs; 2021; 13(1):1865596. PubMed ID: 33382957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG.
    Harvey DJ; Crispin M; Scanlan C; Singer BB; Lucka L; Chang VT; Radcliffe CM; Thobhani S; Yuen CT; Rudd PM
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1047-52. PubMed ID: 18327885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic Glyco-engineering of Monoclonal Antibodies.
    Giddens JP; Wang LX
    Methods Mol Biol; 2015; 1321():375-87. PubMed ID: 26082235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles.
    Ramakrishnan B; Boeggeman E; Pasek M; Qasba PK
    Methods Mol Biol; 2011; 751():281-96. PubMed ID: 21674337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
    J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.